Module 5: Postpartum Concerns and Transition of Care in Patients with Substance Use Disorder
In this module, Dr. Katherine Callaghan and Dr. Leena Mittal cover three major areas to address during the postpartum period, including Neonatal Opioid Withdrawal Syndrome (NOWS) treatment, breastfeeding recommendations, and transition of patient care. They offer insights on common challenges in these areas from both a patient and care team perspective, and outline best practices on reducing challenges to ensure maternal and infant safety.
Module Learning Objectives
Upon completion of this module, participants should be able to...
- Address common prenatal and postpartum concerns in patients with substance use disorders
- Assess and treat Neonatal Opioid Withdrawal Syndrome (NOWS) with pharmacologic and nonpharmacologic approaches
- Collaborate with care team members to establish policy consensus and standardize patient communication
- Apply transition of care best practices for continuous patient care
Katherine Callaghan, MD, is the founder and director of UMass Memorial’s Karen W. Green Clinic for Pregnancy and Recovery. This multidisciplinary clinic provides comprehensive prenatal care and addiction treatment to women with a variety of substance use disorders. “The Green Clinic” seeks to optimize and integrate obstetrical & postpartum care, medication for opioid use disorder (MOUD), psychiatric services, peer support, and social work support to women in recovery, seeking recovery, or actively using substances. Since joining the OB/GYN Department at UMass Memorial in 2014, Dr. Callaghan has led a committee of nurses, pharmacists, addiction specialists, and administrators in drafting, finalizing, and implementing in-patient protocols for initiating MOUD in the pregnant patient, including both a methadone protocol and a buprenorphine protocol. These protocols have both improved and streamlined the process, making MOUD a readily available option for pregnant patients seeking care.
Leena Mittal, MD, is the Chief of the Division of Women's Mental Health at Brigham and Women's Hospital and an Instructor in Psychiatry at Harvard Medical School. She also serves as the Program Director for the Women's Mental Health Fellowship at the Brigham. Dr. Mittal has numerous publications and speaks nationally on the treatment of mental health and substance use conditions throughout pregnancy and the postpartum period. Dr. Mittal is board certified in psychiatry, psychosomatic medicine and addiction medicine. Additionally, Dr. Mittal is the Associate Medical Director for the Massachusetts Child Psychiatry Access Program for Moms (MCPAP for Moms), an innovative statewide consultation service for providers seeing pregnant and postpartum women with mental health and substance use conditions.
Weitzman Institute Disclosure Statement
It is the policy of the Weitzman Institute to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the Weitzman Institute requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
Faculty participating in a Weitzman Institute-sponsored activity must disclose to the planning committee and audience all financial or other relationship(s) with ineligible companies.
In support of improving patient care, Moses/Weitzman Health System Inc. and its Weitzman Institute is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credential Center (ANCC) to provide continuing education for the healthcare team.
By completing this activity, you provide Moses/Weitzman Health System Inc. the permission to share completion data with the ACCME and the certifying board(s).
- 0.75 AAPA Category I CMEThrough Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide American Academy of PAs (AAPA) credit to physician assistants at its activities. Participants should only claim commensurate credit with the extent of their participation in the activity.
- 0.75 AMA PRA Category 1 Credit™Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide AMA PRA Category 1 Credit™ to physicians at its activities via Accreditation Council for Continuing Medical Education (ACCME).
- 0.75 ANCCThrough Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide American Nurses Credentialing Center (ANCC) nursing credit to nurses at its activities.
- 0.75 Participation Hour(s)If you are not able to utilize any of the above credit types, you are able to download an unaccredited Participation Certificate for your records.